Long-Term Survival in Patients Receiving Combination Therapy with Resection and Radiofrequency Ablation for Multi-Focal Hepatocellular Carcinoma Classified as Barcelona Clinic Liver Cancer Stage B: A Retrospective Controlled Study
Jun Yan,1– 3,* Zhongsong Man,3,* Qian Lu,1 Kuansheng Ma2 1Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Institute for Precision Medicine, Tsinghua University, Beijing, People’s Republic of China; 2The Institute of Hepatobiliary Surgery, The First Hospital Affi...
| Published in: | Cancer Management and Research |
|---|---|
| Main Authors: | Yan J, Man Z, Lu Q, Ma K |
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2020-04-01
|
| Subjects: | |
| Online Access: | https://www.dovepress.com/long-term-survival-in-patients-receiving-combination-therapy-with-rese-peer-reviewed-article-CMAR |
Similar Items
Comparable Outcomes in Early Hepatocellular Carcinomas Treated with Trans-Arterial Chemoembolization and Radiofrequency Ablation
by: Benjamin Wei Rong Tay, et al.
Published: (2022-09-01)
by: Benjamin Wei Rong Tay, et al.
Published: (2022-09-01)
Multicenter Study on Transarterial Chemoembolization Combined with Radiofrequency Ablation for Early-Stage Hepatocellular Carcinoma: Primary versus Recurrent HCC
by: Chen YT, et al.
Published: (2024-12-01)
by: Chen YT, et al.
Published: (2024-12-01)
Role of Radiofrequency Ablation in Patients with Hepatocellular Carcinoma Who Undergo Prior Transarterial Chemoembolization: Long-Term Outcomes and Predictive Factors
Published: (2014-09-01)
Published: (2014-09-01)
Sequential or simultaneous transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: A retrospective real‐world study
by: Jianwei Liu, et al.
Published: (2024-06-01)
by: Jianwei Liu, et al.
Published: (2024-06-01)
Transarterial chemoembolization combined with radiofrequency ablation for medium and large hepatocellular carcinoma: insufficient ablation is associated with intrahepatic distant metastasis and extrahepatic metastasis
by: Peng Guo, et al.
Published: (2024-04-01)
by: Peng Guo, et al.
Published: (2024-04-01)
Transarterial chemoembolization with radiofrequency ablation versus hepatectomy in hepatocellular carcinoma beyond the Milan criteria: a retrospective study
by: Yuan H, et al.
Published: (2018-11-01)
by: Yuan H, et al.
Published: (2018-11-01)
Combined radiofrequency ablation or microwave ablation with transarterial chemoembolization can increase efficiency in intermediate-stage hepatocellular carcinoma without more complication: a systematic review and meta-analysis
by: Yao Yang, et al.
Published: (2022-12-01)
by: Yao Yang, et al.
Published: (2022-12-01)
Combining transarterial chemoembolization, radiofrequency ablation, and iodine-125 seed implantation for recurrent hepatocellular carcinoma post-hepatectomy
by: Yong Zhong, et al.
Published: (2025-05-01)
by: Yong Zhong, et al.
Published: (2025-05-01)
The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasion
by: Zhenwei Peng, et al.
Published: (2022-12-01)
by: Zhenwei Peng, et al.
Published: (2022-12-01)
Single-session combined radiofrequency ablation and transarterial chemoembolization in the treatment of hepatocellular carcinoma
by: Mahmoud A. Dawoud, et al.
Published: (2017-12-01)
by: Mahmoud A. Dawoud, et al.
Published: (2017-12-01)
Chemoembolization combined with radiofrequency ablation is the best option for the local treatment of early hepatocellular carcinoma?
by: Hyo-Cheol Kim
Published: (2023-10-01)
by: Hyo-Cheol Kim
Published: (2023-10-01)
Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma
by: Jiwon Yang, et al.
Published: (2024-09-01)
by: Jiwon Yang, et al.
Published: (2024-09-01)
Radiofrequency Ablation versus Resection in Large Single Nodule of Hepatocellular Carcinoma: an Evidence-based Case Report
by: Felix Firyanto Widjaja, et al.
Published: (2019-01-01)
by: Felix Firyanto Widjaja, et al.
Published: (2019-01-01)
Radiofrequency Ablation versus Resection in Large Single Nodule of Hepatocellular Carcinoma: an Evidence-based Case Report
by: Felix Firyanto Widjaja, et al.
Published: (2019-01-01)
by: Felix Firyanto Widjaja, et al.
Published: (2019-01-01)
Progress in Locoregional Interventional Therapy of Primary Hepatocellular Carcinoma
by: ZHOU Shi
Published: (2022-06-01)
by: ZHOU Shi
Published: (2022-06-01)
Transarterial Chemoembolization Plus Radiofrequency Ablation and Iodine-125 Seed Implantation for Hepatocellular Carcinoma in High-Risk Locations: A Propensity Score-Matched Analysis
by: Zhang G, et al.
Published: (2025-01-01)
by: Zhang G, et al.
Published: (2025-01-01)
Transarterial Chemoembolization Combined With Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma After Curative Resection: A 10-Year Single-Center Comparative Study
by: Xin Zheng, et al.
Published: (2021-09-01)
by: Xin Zheng, et al.
Published: (2021-09-01)
Effect of Transarterial Chemoembolization Plus Percutaneous Ethanol Injection or Radiofrequency Ablation for Liver Tumors
by: Chen L, et al.
Published: (2022-08-01)
by: Chen L, et al.
Published: (2022-08-01)
Radiofrequency ablation of hepatocellular carcinoma: Current status, challenges, and prospects
by: Hongye Wang, et al.
Published: (2023-06-01)
by: Hongye Wang, et al.
Published: (2023-06-01)
Management of Hepatocellular Carcinoma: Current Status and Future Directions
Published: (2015-07-01)
Published: (2015-07-01)
Common interventional techniques (single versus combined) in management of hepatocellular carcinoma
by: Mostafa M. Shakweer, et al.
Published: (2016-12-01)
by: Mostafa M. Shakweer, et al.
Published: (2016-12-01)
Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a review
by: Nikolaos Galanakis, et al.
Published: (2018-04-01)
by: Nikolaos Galanakis, et al.
Published: (2018-04-01)
Radiofrequency ablation with or without conventional transarterial chemoembolization for subcapsular versus nonsubcapsular hepatocellular carcinoma within Milan criteria: a propensity score-matched study
by: Haitao Guan, et al.
Published: (2025-12-01)
by: Haitao Guan, et al.
Published: (2025-12-01)
CT-based deep learning radiomics model for predicting proliferative hepatocellular carcinoma: application in transarterial chemoembolization and radiofrequency ablation
by: Hengtao Zhang, et al.
Published: (2025-09-01)
by: Hengtao Zhang, et al.
Published: (2025-09-01)
Enhanced radiofrequency ablation for recurrent hepatocellular carcinoma post-transarterial chemoembolization: a prospective study utilizing twin internally cooled-perfusion electrodes
by: Sungjun Hwang, et al.
Published: (2025-03-01)
by: Sungjun Hwang, et al.
Published: (2025-03-01)
Benefits of step-by-step debulking microwave ablation for huge unresectable hepatocellular carcinoma patients after transcatheter arterial chemoembolization refractoriness
by: Tao Huang, et al.
Published: (2022-12-01)
by: Tao Huang, et al.
Published: (2022-12-01)
Liver resection, radiofrequency ablation, and radiofrequency ablation combined with transcatheter arterial chemoembolization for very-early- and early-stage hepatocellular carcinoma: A systematic review and Bayesian network meta-analysis for comparison of efficacy
by: Yunlong Zhang, et al.
Published: (2022-10-01)
by: Yunlong Zhang, et al.
Published: (2022-10-01)
Radiofrequency Ablation versus Surgical Resection in Elderly Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
by: Jeong-Ju Yoo, et al.
Published: (2024-01-01)
by: Jeong-Ju Yoo, et al.
Published: (2024-01-01)
Radiofrequency ablation with or without transarterial chemoembolization for hepatocellular carcinoma meeting Milan criteria: a focus on tumor progression and recurrence patterns
by: Yong Xie, et al.
Published: (2024-05-01)
by: Yong Xie, et al.
Published: (2024-05-01)
Comparative Study of Long-Term Outcomes of Laparoscopic Liver Resection versus Radiofrequency Ablation for Single Small Hepatocellular Carcinoma Located in Left Lateral Segments of the Liver
by: MeeYoung Kang, et al.
Published: (2023-06-01)
by: MeeYoung Kang, et al.
Published: (2023-06-01)
Percutaneous Radiofrequency Ablation Combined With Transarterial Chemoembolization Plus Sorafenib for Large Hepatocellular Carcinoma Invading the Portal Venous System: A Prospective Randomized Study
by: Xiaoyan Ding, et al.
Published: (2020-10-01)
by: Xiaoyan Ding, et al.
Published: (2020-10-01)
Impact of resection versus radiofrequency ablation on medium-sized hepatocellular carcinomas: Long-term outcome and prognostic factors
by: Yu-Chen Tseng, et al.
Published: (2022-01-01)
by: Yu-Chen Tseng, et al.
Published: (2022-01-01)
Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
by: Jun Young Kim, et al.
Published: (2016-06-01)
by: Jun Young Kim, et al.
Published: (2016-06-01)
Long-term efficacy of transarterial chemoembolization in the treatment of recurrent hepatocellular carcinoma
by: Chao Chen, et al.
Published: (2025-09-01)
by: Chao Chen, et al.
Published: (2025-09-01)
Treatment optimization for recurrent hepatocellular carcinoma: Repeat hepatic resection versus radiofrequency ablation
by: Liang‐He Lu, et al.
Published: (2020-05-01)
by: Liang‐He Lu, et al.
Published: (2020-05-01)
TACE-assisted multi-image guided radiofrequency ablation for the treatment of single hepatocellular carcinoma ≤ 5 cm: a retrospective study
by: Yong Xie, et al.
Published: (2024-04-01)
by: Yong Xie, et al.
Published: (2024-04-01)
Multiple asynchronous recurrence as a predictive factor for refractoriness against locoregional and surgical therapy in patients with intermediate-stage hepatocellular carcinoma
by: Ryosuke Kasuga, et al.
Published: (2024-05-01)
by: Ryosuke Kasuga, et al.
Published: (2024-05-01)
Efficacy of radiofrequency ablation versus laparoscopic liver resection for hepatocellular carcinoma in China:
a comprehensive meta-analysis
by: Zhijun Li, et al.
Published: (2021-04-01)
by: Zhijun Li, et al.
Published: (2021-04-01)
Radiofrequency ablation versus surgical resection in elderly patients with early-stage hepatocellular carcinoma in the era of organ shortage
by: Bin Yu, et al.
Published: (2018-01-01)
by: Bin Yu, et al.
Published: (2018-01-01)
Radiofrequency ablation in the treatment of hepatocellular carcinoma
by: Qingsong Deng, et al.
Published: (2022-12-01)
by: Qingsong Deng, et al.
Published: (2022-12-01)
Similar Items
-
Comparable Outcomes in Early Hepatocellular Carcinomas Treated with Trans-Arterial Chemoembolization and Radiofrequency Ablation
by: Benjamin Wei Rong Tay, et al.
Published: (2022-09-01) -
Multicenter Study on Transarterial Chemoembolization Combined with Radiofrequency Ablation for Early-Stage Hepatocellular Carcinoma: Primary versus Recurrent HCC
by: Chen YT, et al.
Published: (2024-12-01) -
Role of Radiofrequency Ablation in Patients with Hepatocellular Carcinoma Who Undergo Prior Transarterial Chemoembolization: Long-Term Outcomes and Predictive Factors
Published: (2014-09-01) -
Sequential or simultaneous transarterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: A retrospective real‐world study
by: Jianwei Liu, et al.
Published: (2024-06-01) -
Transarterial chemoembolization combined with radiofrequency ablation for medium and large hepatocellular carcinoma: insufficient ablation is associated with intrahepatic distant metastasis and extrahepatic metastasis
by: Peng Guo, et al.
Published: (2024-04-01)
